Valeant Pharmaceutical Interim CEO to Testify Before Congress Next Week – Wall Street Journal


Healthcare Finance News
Valeant Pharmaceutical Interim CEO to Testify Before Congress Next Week
Wall Street Journal
Howard Schiller, interim CEO of Valeant Pharmaceuticals International Inc., VRX 0.42 % is planning to testify at a congressional hearing next week that will explore drug-price increases, according to a company spokeswoman. Also in connection with the¬†…
Former Turing Pharmaceuticals CEO Martin Shkreli Subpoenaed by Congress for Drug Prices HearingABC News
Former pharmaceutical CEO Shkreli changing lawyers in his securities fraud caseNewser
Notorious former pharmaceutical CEO Martin Shkreli to testify before Congressional committeeHealthcare Finance News
FOX 5 Atlanta
all 218 news articles >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd